DICI Interactive Summary

Drug-Induced Cardiac Injury - Safety Officer Toolkit

Drug-Induced Cardiac Injury (DICI) - Safety Officer Interactive Tool

This structured tool supports patient safety officers in identifying, evaluating, and managing drug-induced cardiac injury.

Drug ClassExamplesCardiac Effects
Chemotherapy AgentsAnthracyclines, Trastuzumab, TKIsCardiomyopathy, Heart Failure
Anti-Inflammatory DrugsNSAIDs, CorticosteroidsHypertension, Fluid Retention, Stroke Risk
Psychotropic DrugsTCAs, Atypical AntipsychoticsArrhythmias, Metabolic Syndrome
Antiarrhythmic DrugsAmiodaroneBradycardia, QT Prolongation
Antihypertensive DrugsBeta-blockers, ACE inhibitorsWithdrawal Effects, Hypotension
Illicit DrugsCocaine, AmphetaminesMI, Arrhythmias, Vasoconstriction
MiscellaneousHydroxychloroquine, AntihistaminesQT Prolongation, Cardiomyopathy
MechanismExamplesDescription
Direct Myocardial ToxicityAnthracyclinesFree radical damage causing cardiomyopathy
Ion Channel InterferenceAntiarrhythmics, AntihistaminesQT Prolongation, Risk of Torsades
Coronary Artery ConstrictionCocaineVasospasm leading to ischemia
Negative Inotropic EffectsBeta-blockersReduced contractility, worsening heart failure
Metabolic DisturbancesAntipsychotics, AntidepressantsWeight gain, metabolic syndrome increasing CVD risk
Electrolyte ImbalancesDiureticsHypokalemia-induced arrhythmias
Onset CategoryExampleRisk WindowTime to Onset
ImmediateCocaineUpon UseMinutes to Hours
EarlyNSAIDsInitiation or High DoseDays
SubacuteTrastuzumabEarly Treatment PhaseWeeks to Months
LateAnthracyclinesCumulative Dose DependentMonths to Years
VariableACE inhibitorsWith Dose Changes or Renal ImpairmentAnytime
IdiosyncraticQT Prolongation DrugsUnpredictableSingle Dose or Chronic
Alternative ExplanationPotential Causes
Pre-existing CVDUndiagnosed CAD, coincidental MI
Structural Heart DiseaseHypertrophic Cardiomyopathy
InfectionsViral Myocarditis
Electrolyte ImbalancesDiuretic-induced Hypokalemia
Stress CardiomyopathyTakotsubo Syndrome
Endocrine CausesHyperthyroidism-induced Palpitations
Illicit Substance UseCocaine or Methamphetamine
  • Definition: Structural, functional, or electrophysiological cardiac abnormality temporally linked to drug exposure, excluding other likely causes.
  • Diagnostic Requirements:
    • New cardiac symptoms or abnormal exam
    • Objective evidence (biomarkers, ECG, Echo)
    • Temporal link to drug exposure
    • Reasonable exclusion of other causes
    • Reversibility or rechallenge (if applicable)
  • Example: Reduced LVEF post-Doxorubicin with no other cause = Likely DICI
  • High-risk drugs include anthracyclines, NSAIDs, psychotropics, and illicit substances
  • Common injury mechanisms: oxidative stress, QT prolongation, metabolic effects
  • Time to onset ranges from minutes (cocaine) to years (anthracyclines)
  • Exclude alternative diagnoses before confirming DICI
  • Management: discontinue offending drug, monitor cardiac status, educate patients